Browse All

Current Filters

CLEAR FILTER x

TITLE

Examining the Impact of Comorbid Depression on Healthcare Utilization, Cost, and Outcomes in Patients with Newly Diagnosed Epilepsy in the US

Author:Terman, Samuel   Ong, Alvin   Davis, Tigwa   Yu, Anthony   Huang, Yecheng   Park, CJ   Thornton, Dan   

Session Name:S41: Epilepsy: Public Health and Epidemiology  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S41.002  

Author Institution:University of Michigan, Neurology Dept, Ann Arbor, MI  Xenon Pharmaceuticals Inc., Chelsea, MA  Inovalon Inc., MD  Inovalon Inc., Bowie, MD  Xenon Pharmaceuticals Inc., MA  

Feasibility of an Entirely Remote, Decentralized, Phase 3 Trial of a Light Therapy Device for Parkinson’s Disease

Author:Hussain, Sarrah   Alessi-Fox, Christi   Kostrzebski, Melissa   Murphy, Kathryn   Porto, Michelle   Schmier, Katrina   McGarry, Andrew   Adams, Jamie   Agarwal, Pinky   Aldred, Jason   Andruska, Kristin   Baumgartner, Alexander   Farmer, Jill   Mehanna, Raja   Richard, Irene   Soileau, Michael   Swan, Matthew   Wyant, Kara   Hendrix, Kent   Hendrix, Suzanne   Adams, Dan   Dorsey, E. Ray   

Session Name:P2: Emerging Science 1  

Topic:Movement Disorders  

Program Number:P2.021  

Author Institution:University of California, San Francisco, Reseda, CA  University of Rochester, NY  Clintrex, TX  Evergreen Health, Kirkland, WA  Selkirk Neurology, WA  CMDC, Mountain View, CA  University of Colorado, Aurora, CO  Boro Neurology, Hopewell, NJ  University of Texas Health Science Center At Houston-McGovern Medical School, Houston, TX  Texas Movement Disorder Specialists, PLLC, Georgetown, TX  Mount Sinai Medical Center, New York, NY  University of Michigan, Neurology Dept, Ann Arbor, MI  Pentara Corporation, UT  Photopharmics, Inc., UT  Atria Research and Global Health Institute, NY